8-K: Hempacco Secures $379,288.88 Funding via Convertible Note and Warrants

Hempacco Co., Inc. has entered into a securities purchase agreement with Mast Hill Fund, L.P., resulting in a $379,288.88 convertible promissory note and warrants to purchase 113,786 shares of common stock.

Summary

• Hempacco Co., Inc. has secured a $379,288.88 investment through a securities purchase agreement with Mast Hill Fund, L.P.
• The agreement includes a convertible promissory note and warrants to purchase 113,786 shares of Hempacco's common stock.
• The purchase price for the note and warrants was $341,360, with $6,000 allocated for legal expenses and $27,308.80 for broker-dealer fees, resulting in net funding of $308,051.20 for Hempacco.
• The promissory note has a 12-month maturity, accrues 10% annual interest, and is convertible into common stock at $2.30 per share, subject to adjustments.
• The note requires monthly repayments starting four months after the issue date, with a larger payment for the first six months and smaller payments for the following two months.
• The warrants have a 5-year term and are exercisable at $2.30 per share, also subject to adjustments.
• The proceeds from the transaction are earmarked for fulfilling purchase orders, business development, and operating capital, and cannot be used for debt repayment to insiders or for investments in other entities.

Sentiment

Score: 4

Explanation: The document indicates a need for capital, which is often a sign of financial challenges. The terms of the financing are not particularly favorable to the company, and there are several restrictions and potential risks involved. This suggests a cautious outlook from an investment perspective.

Positives

• Hempacco has secured additional funding to support its operations and growth.
• The convertible note provides a potential source of equity financing in the future.
• The warrants offer an additional incentive for the investor and potential future capital for the company.
• The funds are specifically allocated for business development and operations, which may lead to growth.

Negatives

• The note is unsecured, which may pose a risk to the investor.
• The conversion price and warrant exercise price are subject to adjustments, which could dilute existing shareholders.
• The note has a 10% interest rate, which is a cost to the company.
• The funds are restricted in their use, limiting the company's flexibility.

Risks

• The company may face challenges in meeting the monthly repayment obligations of the note.
• The conversion price of the note can be adjusted downwards if certain events occur, potentially diluting existing shareholders.
• The company is required to obtain shareholder approval for the issuance of shares exceeding a certain cap, which may be difficult to achieve.
• Failure to deliver shares on time after conversion or exercise could result in penalties and be considered an event of default.
• The company is subject to various covenants and restrictions, which may limit its operational flexibility.

Future Outlook

The company is required to file a registration statement for the resale of shares issued under the transaction within 90 days and have it effective within 120 days. The company must also obtain shareholder approval for the issuance of shares exceeding a certain cap.

Industry Context

This type of financing, involving a convertible note and warrants, is common for small and micro-cap companies seeking capital. The terms of the agreement, including the interest rate, conversion price, and warrant terms, are typical for such transactions.

Comparison to Industry Standards

• The 10% interest rate on the convertible note is within the typical range for similar financings in the micro-cap space, where higher risk is often associated with higher interest rates.
• The conversion price of $2.30 per share is a common structure, but the potential for adjustments based on future issuances is a standard anti-dilution measure.
• The 5-year term for the warrants is also typical, providing the investor with a longer-term upside potential.
• The use of a cashless exercise feature for the warrants is a common practice, allowing the investor to exercise without needing to provide additional cash.
• The restrictions on the use of proceeds are also standard, ensuring that the funds are used for the intended purposes.

Stakeholder Impact

• Shareholders may experience dilution due to the potential conversion of the note and exercise of warrants.
• Employees may benefit from the company's ability to fund operations and growth.
• Customers may benefit from the company's ability to fulfill purchase orders.
• Creditors may be impacted by the company's increased debt obligations.

Next Steps

• The company needs to file a registration statement for the resale of shares within 90 days.
• The company needs to obtain shareholder approval for the issuance of shares exceeding the Exchange Cap.
• The company needs to start making monthly repayments on the promissory note starting four months after the issue date.
• The company needs to use the proceeds from the transaction for the specified purposes.

Key Dates

Keywords

convertible note, warrants, securities purchase agreement, common stock, funding, investment, dilution, shareholder approval, repayment, exercise price